Results 191 to 200 of about 1,284,948 (376)

Perivascular Adipose Tissue and Coronary Atherosclerosis: from Biology to Imaging Phenotyping

Current Atherosclerosis Reports, 2019
A. Lin, D. Dey, Dennis T. L. Wong, N. Nerlekar   +3 more
semanticscholar   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Coronary Atherosclerosis in Cases Observed at the Department of Internal Medicine, Tokyo University Hospital

, 1963
Satoru Murao, Ryozo Okada, Kenichi Harumi, Yoshimi Yanai, Masahiro Murayama, Hideo UEDA   +5 more
openalex   +2 more sources

Relationship Between Lifelong Exercise Volume and Coronary Atherosclerosis in Athletes

Circulation, 2017
V. L. Aengevaeren, A. Mosterd, T. Braber, N. Prakken, P. Doevendans, D. Grobbee, P. Thompson, T. Eijsvogels, B. Velthuis   +8 more
semanticscholar   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

A Memorandum of "World Heart Day 2012": Myocardial Infarction Mortality in Women in Birjand, 2008-2009

Journal of Tehran University Heart Center, 2015
Letter to the ...
Toba Kazemi, GholamReza Sharifzadeh
doaj  

Regression of coronary atherosclerosis: is it possible? [PDF]

, 1988
J. Shepherd, C.J. Packard
openalex   +1 more source

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

Atherosclerosis and Responses of Human Isolated Coronary Arteries to Endothelium-Dependent and -Independent Vasodilators

, 1989
Guy Berkenboom, Philippe Unger, Jeanine Fontaine   +2 more
openalex   +2 more sources

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source